11. Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis. Issue 3 (12th September 2013) Authors: Keir, Gregory J; Garfield, Benjamin; Hansell, David M; Loebinger, Michael R; Wilson, Robert; Renzoni, Elisabetta A; Wells, Athol U; Maher, Toby M Journal: Thorax Issue: Volume 69:Issue 3(2014) Page Start: 287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Detecting anxiety and depression in patients diagnosed with an interstitial lung disease. Can we do better?. Issue 8 (November 2014) Authors: Russell, Anne Marie; Maher, Toby M Journal: Respirology Issue: Volume 19:Issue 8(2014) Page Start: 1095 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography. Issue 3 (October 2022) Authors: Khanna, Dinesh; Distler, Oliver; Cottin, Vincent; Brown, Kevin K; Chung, Lorinda; Goldin, Jonathan G; Matteson, Eric L; Kazerooni, Ella A; Walsh, Simon LF; McNitt-Gray, Michael; Maher, Toby M Journal: Journal of scleroderma and related disorders Issue: Volume 7:Issue 3(2022) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial. Issue 10 (October 2018) Authors: Visca, Dina; Mori, Letizia; Tsipouri, Vicky; Fleming, Sharon; Firouzi, Ashi; Bonini, Matteo; Pavitt, Matthew J; Alfieri, Veronica; Canu, Sara; Bonifazi, Martina; Boccabella, Cristina; De Lauretis, Angelo; Stock, Carmel J W; Saunders, Peter; Montgomery, Andrew; Hogben, Charlotte; Stockford, Anna; ... Journal: Lancet Issue: Volume 6:Issue 10(2018) Page Start: 759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression. Issue 1 (16th February 2023) Authors: Khanna, Dinesh; Maher, Toby M; Volkmann, Elizabeth R; Allanore, Yannick; Smith, Vanessa; Assassi, Shervin; Kreuter, Michael; Hoffmann-Vold, Anna-Maria; Kuwana, Masataka; Stock, Christian; Alves, Margarida; Sambevski, Steven; Denton, Christopher P Journal: RMD open Issue: Volume 9:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis. Issue 2 (5th October 2016) Authors: Kreuter, Michael; Bonella, Francesco; Maher, Toby M; Costabel, Ulrich; Spagnolo, Paolo; Weycker, Derek; Kirchgaessler, Klaus-Uwe; Kolb, Martin Journal: Thorax Issue: Volume 72:Issue 2(2017) Page Start: 148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial. Issue 1 (January 2021) Authors: Highland, Kristin B; Distler, Oliver; Kuwana, Masataka; Allanore, Yannick; Assassi, Shervin; Azuma, Arata; Bourdin, Arnaud; Denton, Christopher P; Distler, Jörg H W; Hoffmann-Vold, Anna Maria; Khanna, Dinesh; Mayes, Maureen D; Raghu, Ganesh; Vonk, Madelon C; Gahlemann, Martina; Clerisme-Beaty, Em... Journal: Lancet Issue: Volume 9:Issue 1(2021) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. European consensus statements for interstitial lung disease in systemic sclerosis – Authors' reply. (June 2020) Authors: Hoffmann-Vold, Anna-Maria; Maher, Toby M; Distler, Oliver Journal: Lancet Issue: Volume 2:Number 6(2020) Page Start: e319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Exercise-induced haemoptysis: a thoroughbred cause?. Issue 6 (12th February 2013) Authors: Hull, James H; Menzies-Gow, Andrew; Nicholson, Andrew G; Mohiaddin, Raad H; Maher, Toby M Journal: Thorax Issue: Volume 68:Issue 6(2013) Page Start: 599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF. Issue 8 (21st April 2016) Authors: Mercer, Paul F; Woodcock, Hannah V; Eley, Jessica D; Platé, Manuela; Sulikowski, Michal G; Durrenberger, Pascal F; Franklin, Linda; Nanthakumar, Carmel B; Man, Yim; Genovese, Federica; McAnulty, Robin J; Yang, Shuying; Maher, Toby M; Nicholson, Andrew G; Blanchard, Andy D; Marshall, Richard P; Lu... Journal: Thorax Issue: Volume 71:Issue 8(2016) Page Start: 701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗